Minimal Residual Disease Testing Market Advances with Digital Reporting Platforms
The global minimal residual disease (MRD) testing market size was estimated at USD 2.50 billion in 2024 and is projected to reach USD 4.50 billion by 2030, growing at a CAGR of 10.1% from 2025 to 2030. This growth is primarily fueled by the increasing incidence and prevalence of cancer, advancements in diagnostic technologies, and integration with personalized medicine approaches....
0 ความคิดเห็น 0 หุ้น 14 มุมมอง 0 บทวิจารณ์